Status:
RECRUITING
Prospective Bladder Cancer Infrastructure (ProBCI)
Lead Sponsor:
Prospective Bladder Cancer Infrastructure Foundation
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands
Eligibility Criteria
Inclusion
- Bladder cancer
- Any stage except Ta
- 18 years or older
- Written informed consent
Exclusion
- No exclusion criteria
- Note: participation in ProBCI does not exclude the patient from participation in other studies.
Key Trial Info
Start Date :
October 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2041
Estimated Enrollment :
3600 Patients enrolled
Trial Details
Trial ID
NCT04503577
Start Date
October 4 2020
End Date
December 31 2041
Last Update
August 11 2025
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands
2
ZGT
Almelo, Netherlands
3
Meander Medical Center
Amersfoort, Netherlands
4
Amsterdam UMC, location VUMC
Amsterdam, Netherlands